This morning at #AACR26: data from a phase 1/2 study of an EphA2-targeting bicycle drug conjugate combo with nivolumab in solid tumors.

Back to meeting Original

Back to meeting

Sidney Kimmel Comprehensive Cancer Center· @KimmelCancerCtr · X·2026-04-21 00:05· 2026-04-21Score60

nivolumab

Reading

Immunotherapy: CAR-T in solid tumors, mRNA vaccines, TCR-T

局部 nivolumab · Oral pre-cancer clinical response 85%, 1-year clearance 82%

Body

This morning at #AACR26: data from a phase 1/2 study of an EphA2-targeting bicycle drug conjugate combo with nivolumab in solid tumors.

https://
abstractsonline.com/pp8/#!/21436/p
resentation/12081
…

Heat 0 · 0 likes · 0 replies · 0 reposts

Conference abstracts

CT149NCT05502315matched by 药名 cabozantinib

A phase 2 study of cabozantinib and nivolumab in metastatic castration resistant prostate cancer (CANOPY): Interim analysis

Justine Panian, Lin Liu, Minya Pu, Emily Pittman, Samuel Pena, Archana Ajmera, Yu-Wei Chen, Christos Kyriakopoulos, Qian Qin, James Michael Randall, Tian Zhang, Joshua Michael Lang, Akash Patnaik, Rana R. McKay

Read the abstract →

Source: Sidney Kimmel Comprehensive Cancer Center · x.com